Cerus Corporation
CERS
#7168
Rank
S$0.68 B
Marketcap
S$3.44
Share price
-0.37%
Change (1 day)
98.83%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -S$9.6 Million

According to Cerus Corporation's latest financial reports the company's current earnings are S$0.19 Billion. In 2024 the company made an earning of -S$15.18 Million, an increase over its 2023 earnings that were of -S$36.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$9.6 Million-36.79%
2024 -S$15.18 Million-58.95%
2023 -S$36.96 Million-20.74%
2022 -S$46.63 Million-25.7%
2021 -S$62.76 Million-11.99%
2020 -S$71.31 Million-14%
2019 -S$82.92 Million21.73%
2018 -S$68.12 Million-0.65%
2017 -S$68.56 Million-10.96%
2016 -S$77 Million4.24%
2015 -S$73.87 Million50.99%
2014 -S$48.93 Million-10.08%
2013 -S$54.41 Million184.13%
2012 -S$19.15 Million-7.91%
2011 -S$20.8 Million
2009 -S$29.37 Million-24.69%
2008 -S$39 Million-25.2%
2007 -S$52.13 Million330.54%
2006 -S$12.11 Million1.49%
2005 -S$11.94 Million-61.02%
2004 -S$30.61 Million
2002 -S$75.71 Million10.02%
2001 -S$68.82 Million34.25%
2000 -S$51.26 Million61.02%
1999 -S$31.84 Million-18.81%
1998 -S$39.22 Million93.08%
1997 -S$20.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.77 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
S$18.66 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
S$0.32 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.12 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA